GENE's free cash flow for Q4 2023 was AU$―. For the 2023 fiscal year, GENE's free cash flow was decreased by AU$-3.98M and operating cash flow was AU$―. See a summary of the company’s cash flow.

Cash Flow	TTM	Jun 23	Jun 22	Jun 21	Jun 20	Jun 19
Operating Cash Flow	-	AU$ -9.72M	AU$ -5.66M	-	-	-
Investing Cash Flow	AU$ 139.52K	AU$ -311.94K	AU$ -3.46M	AU$ -748.71K	AU$ 64.79K	AU$ -524.46K
Financing Cash Flow	AU$ -197.92K	AU$ 5.92M	AU$ -279.06K	AU$ 13.69M	AU$ 18.36M	AU$ 3.13M
Cash Flow From Discontinued Operation	-	-	-	-	-	-
Other Cash Adjustment Inside Changein Cash	-	-	-	-	-	-
End Cash Position	AU$ 30.28M	AU$ 7.85M	AU$ 11.50M	AU$ 20.90M	AU$ 14.21M	AU$ 2.13M
Income Tax Paid Supplemental Data	-	-	-	-	-	-
Interest Paid Supplemental Data	-	-	-	-	-	-
Issuance Of Capital Stock	-	-	-	AU$ 15.90M	AU$ 21.79M	AU$ 3.56M
Issuance Of Debt	-	AU$ 6.84M	AU$ -268.59K	AU$ 0.00	AU$ 52.25K	AU$ 0.00
Repayment Of Debt	AU$ -166.48K	AU$ -336.40K	AU$ -268.59K	AU$ -236.89K	AU$ -183.91K	AU$ 0.00
Free Cash Flow	AU$ -4.54M	AU$ -9.74M	AU$ -5.76M	AU$ -7.04M	AU$ -5.75M	AU$ -6.12M
Domestic Sales	-	-	-	-	-	-
Foreign Sales	-	-	-	-	-	-

Currency in AUD

Genetic Technologies Cash Flow

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing